In the last trading session, 0.11 million Corvus Pharmaceuticals Inc (NASDAQ:CRVS) shares changed hands as the company’s beta touched 1.11. With the company’s per share price at $1.87 changed hands at -$0.06 or -3.11% during last session, the market valuation stood at $116.97M. CRVS’s last price was a discount, traded about -68.98% off its 52-week high of $3.16. The share price had its 52-week low at $1.05, which suggests the last value was 43.85% up since then. When we look at Corvus Pharmaceuticals Inc’s average trading volume, we note the 3-month average coming to 237.87K.
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) trade information
Instantly CRVS was in red as seen at the end of in last trading. With action -12.62%, the performance over the past five days has been red. The drop to weekly highs of 2.2200 subtracted -3.11% to the stock’s daily price. The company’s shares are showing year-to-date upside of 6.25%, with the 5-day performance at -12.62% in the red. However, in the 30-day time frame, Corvus Pharmaceuticals Inc (NASDAQ:CRVS) is -18.34% down.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Corvus Pharmaceuticals Inc (CRVS) estimates and forecasts
Data shows that the Corvus Pharmaceuticals Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 22.22% over the past 6 months, a 12.50% in annual growth rate that is considerably lower than the industry average of 15.60%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 19.89%. The 2024 estimates are for Corvus Pharmaceuticals Inc earnings to increase by 14.29%.
CRVS Dividends
Corvus Pharmaceuticals Inc is expected to release its next quarterly earnings report in July.
